Share
Market Research Report

PEPTIC ULCER DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeProton Pump Inhibitors · Potassium-Competitive Acid Blocker (P-CAB) · Antacids · H2- Antagonist · Antibiotics · Ulcer Protective
  • By Disease IndicationGastitis · Gastric Ulcer · Duodenal Ulcer · Gastroesophageal Reflux Disease (GERD)
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In31 Mar 2026
  • Report CodeCMI3246
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Disease Indication
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Product Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
    • Pipeline Analysis
  4. Global Peptic Ulcer Drugs Market, By Product Type, 2021 – 2033, (US$ Billion)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Proton Pump Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Potassium-Competitive Acid Blocker (P-CAB)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Antacids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • H2- Antagonists
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Ulcer Protective
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  5. Global Peptic Ulcer Drugs Market, By Disease Indication, 2021 – 2033, (US$ Billion)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Gastitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Gastric Ulcer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Duodenal Ulcer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Gastroesophageal Reflux Disease (GERD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  6. Global Peptic Ulcer Drugs Market, By Distribution Channel, 2021 – 2033, (US$ Billion)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  7. Global Peptic Ulcer Drugs Market, By Region, 2021 – 2033, (US$ Billion)

    • Overview
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (US$ Billion)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Daewoong Pharmaceutical Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Takeda Pharmaceutical Co., Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Pfizer Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • AstraZeneca plc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • RedHill Biopharma
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Cadila Healthcare Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Novitium Pharma LLC.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Boehringer Ingelheim GmbH
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Eisai Co. Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Yuhan Corporation
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • GlaxoSmithKline plc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
  9. Section

    • Research Methodology
    • About Us